Numis Securities Ltd reissued their add rating on shares of Spire Healthcare Group PLC (LON:SPI) in a research report released on Wednesday morning. Numis Securities Ltd currently has a GBX 360 ($4.70) target price on the stock.
Other equities analysts also recently issued research reports about the stock. JPMorgan Chase & Co. restated a neutral rating and set a GBX 433 ($5.65) price objective on shares of Spire Healthcare Group PLC in a report on Friday, July 15th. Berenberg Bank reiterated a buy rating and issued a GBX 395 ($5.16) price target on shares of Spire Healthcare Group PLC in a report on Wednesday, August 10th. Jefferies Group cut their price target on shares of Spire Healthcare Group PLC from GBX 360 ($4.70) to GBX 335 ($4.37) and set a hold rating on the stock in a report on Tuesday, July 26th. Barclays PLC reiterated an overweight rating and issued a GBX 382 ($4.99) price target on shares of Spire Healthcare Group PLC in a report on Friday, August 26th. Finally, Morgan Stanley reiterated an equal weight rating and issued a GBX 340 ($4.44) price target on shares of Spire Healthcare Group PLC in a report on Thursday, August 25th. Five analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus price target of GBX 372.50 ($4.86).
Shares of Spire Healthcare Group PLC (LON:SPI) opened at 394.50 on Wednesday. Spire Healthcare Group PLC has a 52-week low of GBX 275.00 and a 52-week high of GBX 411.00. The company’s market cap is GBX 1.58 billion. The stock’s 50 day moving average is GBX 364.75 and its 200 day moving average is GBX 345.02.
The business also recently disclosed a dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Thursday, November 17th will be given a GBX 1.30 ($0.02) dividend. The ex-dividend date is Thursday, November 17th. This represents a yield of 0.37%.
In other Spire Healthcare Group PLC news, insider Gordon,Simon sold 92,174 shares of the company’s stock in a transaction that occurred on Tuesday, August 30th. The stock was sold at an average price of GBX 350 ($4.57), for a total value of £322,609 ($421,105.60). Also, insider Gildersleeve,John bought 57,300 shares of the firm’s stock in a transaction dated Wednesday, September 21st. The shares were acquired at an average price of GBX 390 ($5.09) per share, for a total transaction of £223,470 ($291,698.21).
About Spire Healthcare Group PLC
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.